List view / Grid view
10 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
The artemisinin-based combination therapy (ACT), pyronaridine-artesunate, has been shown to be as effective in treating malaria as other drugs...
18 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Novartis is to invest more than $ 100 million to advance research and development of new antimalarials over the next five years...
26 February 2018 | By European Pharmaceutical Review
Scientists in California have undertaken studies that have demonstrated the effectiveness of a sophisticated algorithm in preventing the spread of infectious diseases. The application of AI allows authorities to identify the best use of resources and highlight subtle interaction points that might otherwise be missed.
8 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have shown that two different compounds can safely and effectively be added to treatment regimens to block the transmission of the most common form of malaria...
19 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication...
18 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of the malaria parasite that have grown resistant to one of the currently used drugs...
23 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Chloroquine and hydroxychloroquine could make cancer treatments more effective...
31 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have published two systematic reviews revealing the safety of mefloquine for preventing malaria in travellers...
8 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
New research demonstrates that the malaria treatment, artemisinin can now be rapidly produced by genetically engineered moss at an industrial scale...
21 August 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite has been launched...
17 May 2017 | By Niamh Marriott, Junior Editor
Study shows how a mixture of chitin and silver nanoparticles inhibits growth of mosquito larvae...
20 February 2017 | By Niamh Marriott, Digital Editor
Umeå University researches have established links between patterns of malaria in Kenya and environmental factors measurable by satellite imagery...
15 June 2016 | By Victoria White, Digital Content Producer
Novartis' KAF156 is one of the first antimalarial drug candidates to enter Phase IIb clinical development in more than 20 years...
24 May 2016 | By Victoria White, Digital Content Producer
Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee...
15 December 2015 | By Victoria White
A new fund – created through a £17m donation from GSK and £5m from Comic Relief – will provide targeted grants over the next five years to organisations on the malaria frontline...
Follow: